[Surgical Management of Burn Injury Patients : Comments on the Guidelines on Treatment of Thermal Injuries in Adults]

Overview

Journal Chirurgie (Heidelb)

Specialty General Surgery

Date 2023 Aug 3

PMID 37535094

Authors

Hans-Oliver Rennekampff

Thomas Kremer

Affiliations

Soon will be listed here.

Abstract

The treatment of burn injury patients is a unique challenge for clinicians. The extent of thermal injuries ranges from very small burns to life-threatening burn injuries. Insufficient treatment can result in a substantial impairment in the quality of life. In order to avoid such sequelae a targeted treatment must be carried out. A precise diagnosis determines the necessary treatment. Superficial second-degree burns (2a) not involving the face, hand or joints with a total body surface area smaller than 10% can usually be treated with modern wound dressings in an outpatient setting. Deep second-degree burns (2b) are an indication for debridement. In addition to the classical surgical procedures with tangential excision, enzymatic debridement can also be employed. Similarly, indeterminate burns (2a/2b) are also considered to be an indication for enzymatic debridement. Third-degree burns are treated with early debridement and skin grafting. These patients can also benefit from special dermal replacement procedures for an improvement of the functional and esthetic results. Due to the long-term visible sequelae of burns, aftercare of these patients is indicated.

References

Abouzeid C, Wolfe A, Ni P, Carrougher G, Gibran N, Hammond F . Are burns a chronic condition? Examining patient reported outcomes up to 20 years after burn injury-A Burn Model System National Database investigation. J Trauma Acute Care Surg. 2022; 92(6):1066-1074. PMC: 9133040. DOI: 10.1097/TA.0000000000003547. View

Sinha I, Nabi M, Simko L, Wolfe A, Wiechman S, Giatsidis G . Head and neck burns are associated with long-term patient-reported dissatisfaction with appearance: A Burn Model System National Database study. Burns. 2019; 45(2):293-302. PMC: 9201562. DOI: 10.1016/j.burns.2018.12.017. View

Finnerty C, Jeschke M, Branski L, Barret J, Dziewulski P, Herndon D . Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet. 2016; 388(10052):1427-1436. PMC: 5380137. DOI: 10.1016/S0140-6736(16)31406-4. View

Pereira C, Murphy K, Herndon D . Outcome measures in burn care. Is mortality dead?. Burns. 2004; 30(8):761-71. DOI: 10.1016/j.burns.2004.05.012. View

Taylor S, Sen S, Greenhalgh D, Lawless M, Curri T, Palmieri T . Not all patients meet the 1day per percent burn rule: A simple method for predicting hospital length of stay in patients with burn. Burns. 2017; 43(2):282-289. DOI: 10.1016/j.burns.2016.10.021. View

Busche M, Jacobs D, Rennekampff H . Does Increased Patient Load Improve Mortality in Burns?: Identifying Benchmark Parameters Defining Quality of Burn Care. Ann Plast Surg. 2019; 82(4):386-392. DOI: 10.1097/SAP.0000000000001844. View

Hostler D, Weaver M, Ziembicki J, Kowger H, McEntire S, Rittenberger J . Admission temperature and survival in patients admitted to burn centers. J Burn Care Res. 2013; 34(5):498-506. DOI: 10.1097/BCR.0b013e3182a231fb. View

Ziegler B, Kenngott T, Fischer S, Hundeshagen G, Hartmann B, Horter J . Early hypothermia as risk factor in severely burned patients: A retrospective outcome study. Burns. 2019; 45(8):1895-1900. DOI: 10.1016/j.burns.2019.07.018. View

Alvarado R, Chung K, Cancio L, Wolf S . Burn resuscitation. Burns. 2008; 35(1):4-14. DOI: 10.1016/j.burns.2008.03.008. View

10.

Rousseau A, Losser M, Ichai C, Berger M . ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr. 2013; 32(4):497-502. DOI: 10.1016/j.clnu.2013.02.012. View

11.

Morley L, Tang T, Yasmin E, Norman R, Balen A . Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017; 11:CD003053. PMC: 6486196. DOI: 10.1002/14651858.CD003053.pub6. View

12.

Wasiak J, Cleland H, Campbell F, Spinks A . Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2013; (3):CD002106. PMC: 7065523. DOI: 10.1002/14651858.CD002106.pub4. View

13.

Wasiak J, Cleland H . Burns: dressings. BMJ Clin Evid. 2015; 2015. PMC: 4501337. View

14.

Ugburo A, Atoyebi O, Oyeneyin J, Sowemimo G . An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching Hospital. Burns. 2003; 30(1):43-8. DOI: 10.1016/j.burns.2003.09.016. View

15.

Barajas-Nava L, Lopez-Alcalde J, Roque I Figuls M, Sola I, Bonfill Cosp X . Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev. 2013; (6):CD008738. PMC: 11303740. DOI: 10.1002/14651858.CD008738.pub2. View

16.

Claes K, Hoeksema H, Vyncke T, Verbelen J, De Coninck P, De Decker I . Evidence Based Burn Depth Assessment Using Laser-Based Technologies: Where Do We Stand?. J Burn Care Res. 2020; 42(3):513-525. DOI: 10.1093/jbcr/iraa195. View

17.

Wang R, Zhao J, Zhang Z, Cao C, Zhang Y, Mao Y . Diagnostic Accuracy of Laser Doppler Imaging for the Assessment of Burn Depth: A Meta-analysis and Systematic Review. J Burn Care Res. 2019; 41(3):619-625. DOI: 10.1093/jbcr/irz203. View

18.

Hyland E, DCruz R, Menon S, Chan Q, Harvey J, Lawrence T . Prospective, randomised controlled trial comparing Versajet™ hydrosurgery and conventional debridement of partial thickness paediatric burns. Burns. 2015; 41(4):700-7. DOI: 10.1016/j.burns.2015.02.001. View

19.

Rosenberg L, Krieger Y, Bogdanov-Berezovski A, Silberstein E, Shoham Y, Singer A . A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT. Burns. 2013; 40(3):466-74. DOI: 10.1016/j.burns.2013.08.013. View

20.

Hirche C, Citterio A, Hoeksema H, Koller J, Lehner M, Martinez J . Eschar removal by bromelain based enzymatic debridement (Nexobrid) in burns: An European consensus. Burns. 2017; 43(8):1640-1653. DOI: 10.1016/j.burns.2017.07.025. View